4//SEC Filing
Arno Therapeutics, Inc 4
Accession 0000914190-13-000805
CIK 0001195116operating
Filed
Nov 5, 7:00 PM ET
Accepted
Nov 6, 4:46 PM ET
Size
10.6 KB
Accession
0000914190-13-000805
Insider Transaction Report
Form 4
Reizman Yacov
Director
Transactions
- Award
Stock Option (right to buy)
2013-11-04+68,448→ 68,448 totalExercise: $2.40Exp: 2023-11-04→ Common Stock (68,448 underlying)
Holdings
- 38,287(indirect: By FCC Ltd.)
Warrants (right to buy)
Exercise: $8.80From: 2010-09-09Exp: 2015-09-09→ Common Stock (38,287 underlying) - 38,285(indirect: By FCC Ltd.)
Common Stock
- 3,750
Stock Option (right to buy)
Exercise: $8.00Exp: 2020-11-05→ Common Stock (3,750 underlying) - 15,750(indirect: By FCC Ltd.)
2010 Class B Warrants
Exercise: $3.08From: 2010-09-09Exp: 2015-09-09→ Common Stock (15,750 underlying)
Footnotes (3)
- [F1]The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
- [F2]Vests in three equal annual installments commencing 11/5/11.
- [F3]Vests in equal 36-monthly installments commencing 12/4/13.
Documents
Issuer
Arno Therapeutics, Inc
CIK 0001195116
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001195116
Filing Metadata
- Form type
- 4
- Filed
- Nov 5, 7:00 PM ET
- Accepted
- Nov 6, 4:46 PM ET
- Size
- 10.6 KB